BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 27662264)

  • 1. Pharmacokinetics of guaifenesin, pseudoephedrine and hydrocodone in a combination oral liquid formulation, administered as single and multiple doses in healthy Chinese volunteers, and comparison with data for individual compounds formulated as Antuss®.
    Deng S; Huang W; Ni X; Zhang M; Lu H; Wang Z; Hu J; Zhu X; Qiu C; Shang D; Zhang Y; Xiong L; Wen Y
    Xenobiotica; 2017 Oct; 47(10):870-878. PubMed ID: 27662264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single- and multiple-dose pharmacokinetics of a hydrocodone bitartrate extended-release tablet formulated with abuse-deterrence technology in healthy, naltrexone-blocked volunteers.
    Darwish M; Yang R; Tracewell W; Robertson P; Bond M
    Clin Ther; 2015 Feb; 37(2):390-401. PubMed ID: 25542074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability of pseudoephedrine from controlled release formulations in the presence of guaifenesin in human volunteers.
    Pade V; Aluri J; Manning L; Stavchansky S
    Biopharm Drug Dispos; 1995 Jul; 16(5):381-91. PubMed ID: 8527687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-dose pharmacokinetics of 2 or 3 tablets of biphasic immediate-release/extended-release hydrocodone bitartrate/acetaminophen (MNK-155) under fed and fasted conditions: two randomized open-label trials.
    Devarakonda K; Kostenbader K; Giuliani MJ; Young JL
    BMC Pharmacol Toxicol; 2015 Nov; 16():31. PubMed ID: 26614499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailability of paracetamol, phenylephrine hydrochloride and guaifenesin in a fixed-combination syrup versus an oral reference product.
    Janin A; Monnet J
    J Int Med Res; 2014 Apr; 42(2):347-59. PubMed ID: 24553480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common cold and influenza symptom management: the use of pharmacokinetic considerations to predict the efficacy of a twice-daily treatment for colds and flu.
    Stillings M; Little S; Sykes J
    Curr Med Res Opin; 2003; 19(8):791-9. PubMed ID: 14687451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple-dose pharmacokinetics and safety of an ibuprofen-pseudoephedrine cold suspension in children.
    Gelotte CK; Prior MJ; Pendley C; Zimmerman B; Lavins BJ
    Clin Pediatr (Phila); 2010 Jul; 49(7):678-85. PubMed ID: 20356918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, double-blind, parallel-group, multicenter, placebo-controlled study of the safety and efficacy of extended-release guaifenesin/pseudoephedrine hydrochloride for symptom relief as an adjunctive therapy to antibiotic treatment of acute respiratory infections.
    LaForce C; Gentile DA; Skoner DP
    Postgrad Med; 2008 Jul; 120(2):53-9. PubMed ID: 18654069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A prospective multicenter randomized controlled clinical study on the efficacy and safety of Guaifenesin compound pseudoephedrine hydrochloride oral solution].
    ; Lu Q
    Zhonghua Er Ke Za Zhi; 2010 Mar; 48(3):204-7. PubMed ID: 20426957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy, fasting Korean male volunteers.
    Kim BH; Shin KH; Kim J; Lim KS; Kim KP; Kim JR; Cho JY; Shin SG; Jang IJ; Yu KS
    Clin Ther; 2009 Nov; 31(11):2755-64. PubMed ID: 20110017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of guaifenesin following administration of multiple doses to exercised Thoroughbred horses.
    Knych HK; Stanley SD; Benson D; Arthur RM
    J Vet Pharmacol Ther; 2016 Aug; 39(4):416-9. PubMed ID: 26763117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guaifenesin Pharmacokinetics Following Single-Dose Oral Administration in Children Aged 2 to 17 Years.
    Thompson GA; Solomon G; Albrecht HH; Reitberg DP; Guenin E
    J Clin Pharmacol; 2016 Jul; 56(7):894-901. PubMed ID: 26632082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of guaifenesin in human plasma by liquid chromatography in the presence of pseudoephedrine.
    Aluri JB; Stavchansky S
    J Pharm Biomed Anal; 1993 Sep; 11(9):803-8. PubMed ID: 8218524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of single and multiple doses of pseudoephedrine in the treatment of nasal congestion associated with common cold.
    Eccles R; Jawad MS; Jawad SS; Angello JT; Druce HM
    Am J Rhinol; 2005; 19(1):25-31. PubMed ID: 15794071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioavailability of two oral formulations of loratadine 20 mg with concomitant ketoconazole: an open-label, randomized, two-period crossover comparison in healthy Mexican adult volunteers.
    Piñeyro-López A; Pineyro-Garza E; Torres-Alanís O; Reyes-Araiza R; Gómez Silva M; Wacksman N; Lujàn Rangel R; de Lago A; Trejo D; Gonzàlez-de la Parra M; Namur S
    Clin Ther; 2006 Jan; 28(1):110-5. PubMed ID: 16490584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
    Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pharmacokinetic evaluation of single and multiple doses of extended-release hydrocodone bitartrate in subjects experiencing surgical or osteoarthritic pain.
    Robinson CY; Rubino CM; Farr SJ
    J Opioid Manag; 2015; 11(5):405-15. PubMed ID: 26535968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic Studies in Healthy Subjects for the Development of an Extended-Release Tablet Formulation of Guaifenesin: A 505(b)(2) New Drug Application Approval.
    Vilson L; Owen JS
    Clin Pharmacol Drug Dev; 2013 Jan; 2(1):25-32. PubMed ID: 27121557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended-Release Guaifenesin/Pseudoephedrine Hydrochloride for Symptom Relief in Support of a Wait-and-See Approach for the Treatment of Acute Upper Respiratory Tract Infections: A Randomized, Double-Blind, Placebo-Controlled Study.
    Septimus EJ; Albrecht HH; Solomon G; Shea T; Guenin EP
    Curr Ther Res Clin Exp; 2017; 84():54-61. PubMed ID: 28761581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.